Publications by authors named "Andrew D Kelly"

Claim this Profile
V
Validation of comprehensive genomic profiling for prognostic and potential therapeutic molecular classification of endometrial cancer.
Brian M Slomovitz, Natalie Danziger, Julia C F Quintanilha, Andrew D Kelly, Gerald Li

Int J Gynecol Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dynamic microRNA profile that tracks a chemotherapy resistance phenotype in osteosarcoma. Implications for novel therapeutics.
Christopher E Lietz, Erik T Newman, Andrew D Kelly, David H Xiang, Ziying Zhang

medRxiv· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide DNA methylation patterns reveal clinically relevant predictive and prognostic subtypes in human osteosarcoma.
Christopher E Lietz, Erik T Newman, Andrew D Kelly, David H Xiang, Ziying Zhang

Commun Biol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pan-cancer landscape of (PD-L1) rearrangements in 283,050 patient samples, its correlation with PD-L1 protein expression, and immunotherapy response.
Andrew D Kelly, Karthikeyan Murugesan, Zheng Kuang, Meagan Montesion, Jeffrey S Ross

J Immunother Cancer· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Fusion-Positive Case of Breast Cancer With Response to Alectinib.
Andrew D Kelly, Tom Wiklund, Juha Kononen, James Creeden

JCO Precis Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic and epigenomic predictors of response to guadecitabine in relapsed/refractory acute myelogenous leukemia.
Woonbok Chung, Andrew D Kelly, Patricia Kropf, Henry Fung, Jaroslav Jelinek

Clin Epigenetics· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demethylator phenotypes in acute myeloid leukemia.
Andrew D Kelly, Jozef Madzo, Priyanka Madireddi, Patricia Kropf, Charly R Good

Leukemia· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer.
Charly Ryan Good, Shoghag Panjarian, Andrew D Kelly, Jozef Madzo, Bela Patel

Cancer Res· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetics and Precision Oncology.
Rachael J Werner, Andrew D Kelly, Jean-Pierre J Issa

Cancer J· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An imprinted non-coding genomic cluster at 14q32 defines clinically relevant molecular subtypes in osteosarcoma across multiple independent datasets.
Katherine E Hill, Andrew D Kelly, Marieke L Kuijjer, William Barry, Ahmed Rattani

J Hematol Oncol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The promise of epigenetic therapy: reprogramming the cancer epigenome.
Andrew D Kelly, Jean-Pierre J Issa

Curr Opin Genet Dev· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-155 expression is independently predictive of outcome in chordoma.
Eiji Osaka, Andrew D Kelly, Dimitrios Spentzos, Edwin Choy, Xiaoqian Yang

Oncotarget· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32.
Andrew D Kelly, Benjamin Haibe-Kains, Katherine A Janeway, Katherine E Hill, Eleanor Howe

Genome Med· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation sequencing and microarray-based interrogation of microRNAs from formalin-fixed, paraffin-embedded tissue: preliminary assessment of cross-platform concordance.
Andrew D Kelly, Katherine E Hill, Mick Correll, Lan Hu, Yaoyu E Wang

Genomics· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A microRNA activity map of human mesenchymal tumors: connections to oncogenic pathways; an integrative transcriptomic study.
Elena Fountzilas, Andrew D Kelly, Antonio R Perez-Atayde, Jeffrey Goldsmith, Panagiotis A Konstantinopoulos

BMC Genomics· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolomic profiling from formalin-fixed, paraffin-embedded tumor tissue using targeted LC/MS/MS: application in sarcoma.
Andrew D Kelly, Susanne B Breitkopf, Min Yuan, Jeffrey Goldsmith, Dimitrios Spentzos

PLoS One· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis